Global Cell-based Assays Market Intelligence Report 2018 - Key Players are Thermo Fisher, PerkinElmer, Bio-Rad, Merck KGaA, and GE -

One of the key growth contributors for the market is the rise in the use of cell-based assays for high throughput screening. A major challenge experienced by the buyers is the high costs and complexity associated with shipping of the product.

The report provides actionable insights to improve source-to-contract cycle performance in the Global Cell-based Assays Market. It helps sourcing professionals formulate better category strategies, enhance savings, understand supplier and market challenges, and implement sourcing best practices.

The report provides up-to-date information about market shifts and potential risks, as well as in-depth knowledge of products and services, which can help in planning and in executing category management activities. It focuses on the cost-saving aspects of procurement and on providing insights that can lead to optimization of category spend.

The advances in combinatorial biology and chemistry have led to a proliferation of compounds that need to be tested for their interactions with the target. Furthermore, drug responses based on biochemical assays do not accurately reflect tissue-specific responses, as the activity of a small molecule is different in a cellular context as compared with the activity of the molecule in a biochemical assay. This has led to increased adoption of in vitro cell-based assays as they provide an early and accurate representation of the toxicity of various compounds.

Key Suppliers

  • Thermo Fisher
  • PerkinElmer
  • Bio-Rad
  • Merck KGaA
  • GE

Key Topics Covered

Part 1: Category at a Glance

Part 2: Scope of the Report

Part 3: Market Insights

Part 4: Supply Market Insights

Part 5: Pricing Insights

Part 6: Procurement Insights

Part 7: Top Five Suppliers

For more information about this report visit

Back to news